Lexaria Bioscience Corp. (OTCMKTS:LXRP – Get Free Report) passed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $0.22 and traded as high as $0.25. Lexaria Bioscience shares last traded at $0.22, with a volume of 2,151,500 shares trading hands.
Lexaria Bioscience Price Performance
The company has a debt-to-equity ratio of 0.01, a quick ratio of 8.01 and a current ratio of 8.52. The business’s 50-day moving average is $0.22.
About Lexaria Bioscience
Lexaria Bioscience Corp. operates in the drug delivery platform business. It develops and out-licenses its DehydraTECH technology for the delivery of bioactive compounds that promotes healthy ingestion methods, lower overall dosing, and higher effectiveness in active molecule delivery. The company has licensed DehydraTECH to various companies operating in the nicotine, pharmaceutical, nutraceutical, and vitamin industries.
Read More
- Five stocks we like better than Lexaria Bioscience
- Energy and Oil Stocks Explained
- S&P 500 Hitting Resistance: These 3 Stocks Offer the Best Upside
- What Are Dividend Contenders? Investing in Dividend Contenders
- Nike’s Post-Earnings Drop Presents a Buying Opportunity
- Canada Bond Market Holiday: How to Invest and Trade
- Microsoft’s Targeted Upside Might Be Too Good to Ignore
Receive News & Ratings for Lexaria Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lexaria Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
